These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib. Hrachovec JB; Mora M JAMA; 2001 Nov; 286(19):2398; author reply 2399-400. PubMed ID: 11712924 [No Abstract] [Full Text] [Related]
10. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib. Wright JM; Perry TL; Bassett KL; Chambers GK JAMA; 2001 Nov; 286(19):2398-400. PubMed ID: 11712925 [No Abstract] [Full Text] [Related]
11. Toxic epidermal necrolysis as a complication of treatment with celecoxib. Perna AG; Woodruff CA; Markus RF; Hsu S Dermatol Online J; 2003 Dec; 9(5):25. PubMed ID: 14996398 [No Abstract] [Full Text] [Related]
12. Case of cholestatic hepatitis with celecoxib did not fulfil international criteria. Arellano FM; Zhao SZ; Reynolds MW BMJ; 2002 Mar; 324(7340):789. PubMed ID: 11923170 [No Abstract] [Full Text] [Related]
13. Gastropathy due to celecoxib, a cyclooxygenase-2 inhibitor. Mohammed S; Croom DW N Engl J Med; 1999 Jun; 340(25):2005-6. PubMed ID: 10383283 [No Abstract] [Full Text] [Related]
14. Pain management in patients with osteoarthritis. Finucane TE JAMA; 2003 Jul; 290(1):36; author reply 36. PubMed ID: 12837705 [No Abstract] [Full Text] [Related]
15. Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group. Dahlén B; Szczeklik A; Murray JJ; N Engl J Med; 2001 Jan; 344(2):142. PubMed ID: 11188419 [No Abstract] [Full Text] [Related]
18. COX-2 inhibitors. Jones DB Med J Aust; 2001 Apr; 174(7):368; author reply 368-9. PubMed ID: 11346118 [No Abstract] [Full Text] [Related]
19. Cholestatic hepatitis in association with celecoxib. Classification of drug associated liver dysfunction is questionable. Mohammed F; Smith AD BMJ; 2002 Jul; 325(7357):220; author reply 220. PubMed ID: 12142317 [No Abstract] [Full Text] [Related]
20. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients. Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]